A new FDA-approved use for Zepbound opens access for Medicare patients.
Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea , the Centers for Medicare & Medicaid Services confirmed to CNBC. That opens the door for broader coverage of and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss specifically. Medicare Part D plans can cover obesity drugs if they are used for an additional medically accepted purpose approved by the Food and Drug Administration.
That opens the door for broader access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss. Demand for the injection has soared over the last year despite its roughly In a statement to CNBC, a spokesperson for the Centers for Medicare & Medicaid Services said'current Medicare Part D and Medicaid coverage rules apply' to Zepbound following itsadditional medically accepted purpose. The spokesperson added that Part D plans may consider using prior authorization – a process where a provider must first get approval from an insurer – for those drugs to ensure they are being used for that specific purpose. The FDA on Dec. 20 cleared Zepbound for patients with obesity and moderate-to-severe forms of obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep due to narrowed or blocked airways. That made Zepbound the first drug treatment cleared for the estimated 20 million people with those forms of the disease, according to Eli Lilly.of lowering cardiovascular risks. The diabetes counterparts of Wegovy and Zepbound – Ozempic and Mounjaro, respectively – are covered by Medicare and most insurance plans.Both Novo Nordisk and Eli Lilly are studying their weight loss medicines as treatments for fatty liver disease, chronic kidney disease, sleep apnea and more. To be covered, those drugs would need to return late-stage trial results and then be submitted for FDA approval for those use
MEDICARE OBESITY ZEBOUND SLEEP APNEA FDA APPROVAL
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Manning, Luke Kuechly, and Terrell Suggs Among 2025 Pro Football Hall of Fame FinalistsTwo-time Super Bowl MVP Eli Manning, former Defensive Players of the Year Luke Kuechly and Terrell Suggs, and prolific tight end Antonio Gates are among the 15 modern-era finalists for the 2025 Pro Football Hall of Fame class.
Read more »
Eli Manning, Luke Kuechly, Terrell Suggs Headline 2025 Pro Football Hall of Fame FinalistsTwo-time Super Bowl MVP Eli Manning and former Defensive Players of the Year Luke Kuechly and Terrell Suggs are among the finalists for the 2025 Pro Football Hall of Fame.
Read more »
Eli Manning Named Finalist for Pro Football Hall of FameFormer New York Giants quarterback Eli Manning is one step closer to football immortality as he's named a finalist for the Pro Football Hall of Fame's Class of 2025.
Read more »
Emerging Tight End Eli Stowers Could Be a Target for the SaintsThis article discusses the potential of Eli Stowers, a tight end who played with the Vanderbilt Commodores, as a future NFL prospect.
Read more »
Eli Manning, Luke Kuechly and Terrell Suggs Among 2025 Pro Football Hall of Fame FinalistsFormer Super Bowl MVP Eli Manning and other NFL legends are in the running for the Pro Football Hall of Fame
Read more »
Eli Manning Named Modern-Era Finalist for Pro Football Hall of FameEli Manning, former quarterback for the New York Giants, is a finalist for enshrinement in the Pro Football Hall of Fame in 2025.
Read more »